House

Oversight Committee Seeks Purdue OxyContin Documents

On March 21, House Oversight Committee Chairman Elijah Cummings (D-MD) and Rep. Mark DeSaulnier (D-CA) sent a letter to Purdue Pharma requesting documents related to how it has aggressively marketed OxyContin, a key player in the ongoing opioid crisis. The documents requested include the list of Sacklers, the

Hearings

House Committee on Energy and Commerce: “The Fiscal Year 2020 HHS Budget”
Tuesday, March 12, 2019: The Health Subcommittee held a hearing with Health and Human Services Secretary (HHS) Alex Azar on President Trump’s budget request related to the U.S. Department of Health and Human Services (HHS) and its agencies for fiscal year (FY)

Hearings

House Committee on Energy and Commerce: “Strengthening Our Health Care System: Legislation to Lower Consumer Costs and Expand Access”
Wednesday, March 6, 2019: The House Committee on Energy and Commerce held a hearing on lowering consumer costs and expanding access to health care. Find a link to witness testimonies, member statements and the hearing

Hearings

House Committee on Energy and Commerce: “Confronting a Growing Public Health Threat: Measles Outbreaks in the U.S.”
Wednesday, Feb. 27, 2019: The House Energy and Commerce Committee’s Oversight and Investigations Subcommittee held hearing on the current measles outbreak and response efforts. This hearing focused on the need to combat information that discourages individuals from

Grassley, Wyden Investigate Rising Insulin Prices

On Feb. 22, Senate Finance committee Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) launched a probe on the rising cost of insulin, requesting information from drug manufacturers Eli Lilly, Novo Nordisk and Sanofi on recent price increases of up to 500 percent. The letters were sent

House Hearings

House Committee on Energy and Commerce, Subcommittee on Health: Texas v. United States: The Republican Lawsuit and Its Impacts on Americans with Pre-Existing Conditions

On Feb. 6, the House Committee on Energy and Commerce’s subcommittee on health held a hearing on how a federal judge’s ruling in Texas could affect protections of

House Hearings

Oversight and Reform Committee: Examining the Actions of Drug Companies in Raising Prescription Drug Prices
On Jan. 29, the House Committee on Oversight and Reform held a hearing to determine business practices of pharmaceutical manufacturers as well as possible explanations for and solutions to rising drug prices. Find a link to witness testimonies,